Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials.

Eikelboom JW, Mundl H, Alexander JH, Caso V, Connolly SJ, Coppolecchia R, Gebel M, Hart RG, Holberg G, Keller L, Patel MR, Piccini JP, Rao SV, Shoamanesh A, Tamm M, Viethen T, Yassen A, Bonaca MP

Open source

DOI: 10.1016/j.jacc.2023.12.004
Published: 2024 Feb 13
Container: Journal of the American College of Cardiology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jacc.2023.12.004,
  title = {Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials.},
  author = {Eikelboom JW and Mundl H and Alexander JH and Caso V and Connolly SJ and Coppolecchia R and Gebel M and Hart RG and Holberg G and Keller L and Patel MR and Piccini JP and Rao SV and Shoamanesh A and Tamm M and Viethen T and Yassen A and Bonaca MP},
  year = {2024},
  journal = {Journal of the American College of Cardiology},
  doi = {10.1016/j.jacc.2023.12.004},
  url = {https://doi.org/10.1016/j.jacc.2023.12.004}
}

RIS

TY  - JOUR
TI  - Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials.
AU  - Eikelboom JW
AU  - Mundl H
AU  - Alexander JH
AU  - Caso V
AU  - Connolly SJ
AU  - Coppolecchia R
AU  - Gebel M
AU  - Hart RG
AU  - Holberg G
AU  - Keller L
AU  - Patel MR
AU  - Piccini JP
AU  - Rao SV
AU  - Shoamanesh A
AU  - Tamm M
AU  - Viethen T
AU  - Yassen A
AU  - Bonaca MP
PY  - 2024
JO  - Journal of the American College of Cardiology
DO  - 10.1016/j.jacc.2023.12.004
UR  - https://doi.org/10.1016/j.jacc.2023.12.004
ER  -

APA

JW, E., H, M., JH, A., V, C., SJ, C., R, C., M, G., RG, H., G, H., L, K., MR, P., JP, P., SV, R., A, S., M, T., T, V., A, Y., & MP, B. (2024). Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials.. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2023.12.004

Source records

pubmed · retrieved 2026-09-26T22:58:37.204Z
europe-pmc · retrieved 2026-09-26T22:58:37.219Z